Prevalence of human papillomavirus in squamous cell carcinomas of the soft palate

Journal of Clinical Pathology

Volumn 68, Issue 11, 2015, Pages 942-943

  Frandsen, Vibe Lyng ^a   Larsen, Christian Grønhøj ^a   Von Buchwald, Christian ^a  

^a University of Copenhagen   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P16;

CANCER LOCALIZATION; HUMAN; LETTER; LYMPHOID TISSUE; META ANALYSIS (TOPIC); MOUTH CARCINOMA; PAPILLOMAVIRUS INFECTION; PREVALENCE; PRIORITY JOURNAL; SOFT PALATE SQUAMOUS CELL CARCINOMA; SQUAMOUS CELL CARCINOMA; SQUAMOUS EPITHELIUM; HEAD AND NECK TUMOR; PAPILLOMAVIRUS INFECTIONS; PATHOLOGY; SOFT PALATE; VIROLOGY;

CARCINOMA, SQUAMOUS CELL; HEAD AND NECK NEOPLASMS; HUMANS; PALATE, SOFT; PAPILLOMAVIRUS INFECTIONS; PREVALENCE;

EID: 84945175148     PISSN: 00219746     EISSN: 14724146     Source Type: Journal    
DOI: 10.1136/jclinpath-2015-203081     Document Type: Letter

References (22)

1. Schache AG, Liloglou T, Risk JM, et al. Evaluation of human papilloma virus diagnostic testing in oropharyngeal squamous cell carcinoma: sensitivity, specificity, and prognostic discrimination. Clin Cancer Res 2011;17:6262-71.
2. D'Souza G, Kreimer AR, Viscidi R, et al. Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med 2007;356:1944-56.
3. Dayyani F, Etzel CJ, Liu M, et al. Meta-analysis of the impact of human papillomavirus (HPV) on cancer risk and overall survival in head and neck squamous cell carcinomas (HNSCC). Head Neck Oncol 2010;2:15.
4. Iyer NG, Nixon IJ, Palmer F, et al. Surgical management of squamous cell carcinoma of the soft palate: factors predictive of outcome. Head Neck 2012;34:1071-80.
5. Gronhoj Larsen C, Gyldenløve M, Jensen DH, et al. Correlation between human papillomavirus and p16 overexpression in oropharyngeal tumours: a systematic review. Br J Cancer 2014;110:1587-94.
6. Garnaes E, Kiss K, Andersen L, et al. A high and increasing HPV prevalence in tonsillar cancers in Eastern Denmark, 2000-2010: The largest registry-based study to date. Int J Cancer 2015;136:2196-203.
7. O'Rorke MA, Ellison MV, Murray LJ, et al. Human papillomavirus related head and neck cancer survival: a systematic review and meta-analysis. Oral Oncol 2012;48:1191-201.
8. Ang KK, Harris J, Wheeler R, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 2010;363:24-35.
9. Lassen P, Eriksen JG, Hamilton-Dutoit S, et al. Effect of HPV-associated p16INK4A expression on response to radiotherapy and survival in squamous cell carcinoma of the head and neck. J Clin Oncol 2009;27:1992-8.
10. Klussmann JP, Weissenborn SJ, Wieland U, et al. Human papillomavirus-positive tonsillar carcinomas: a different tumor entity? Med Microbiol Immunol 2003;192:129-32.
11. Kreimer AR, Clifford GM, Boyle P, et al. Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev 2005;14: 467-75.
12. Rodrigo JP, Heideman DAM, García-Pedrero JM, et al. Time trends in the prevalence of HPV in oropharyngeal squamous cell carcinomas in northern Spain (1990-2009). Int J Cancer 2014; 134:487-92.
13. Nasman A, Attner P, Hammarstedt L, et al. Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: an epidemic of viral-induced carcinoma?. Int J Cancer 2009;125:362-6.
14. Kim M-J, Ki M-S, Kim K, et al. Different protein expression associated with chemotherapy response in oropharyngeal cancer according to HPV status. BMC Cancer 2014;14:824.
15. Park WS, Ryu J, Cho KH, et al. Human papillomavirus in oropharyngeal squamous cell carcinomas in Korea: use of G1 cycle markers as new prognosticators. Head Neck 2012;34: 1408-17.
16. Bussu F, Sali M, Gallus R, et al. Human papillomavirus (HPV) infection in squamous cell carcinomas arising from the oropharynx: detection of HPV DNA and p16 immunohistochemistry as diagnostic and prognostic indicators-a pilot study. Int J Radiat Oncol Biol Phys 2014;89:1115-20.
17. Hoffmann M, Tribius S, Quabius ES, et al. HPV DNA, E6∗I-mRNA expression and p16INK4A immunohistochemistry in head and neck cancer-how valid is p16INK4A as surrogate marker? Cancer Lett 2012;323:88-96.
18. Ukpo OC, Pritchett CV, Lewis JE, et al. Human papillomavirus-associated oropharyngeal squamous cell carcinomas: primary tumor burden and survival in surgical patients. Ann Otol Rhinol Laryngol 2009;118:368-73.
19. Cerezo L, de la Torre A, Hervás A, et al. Oropharyngeal cancer related to Human Papilloma Virus: incidence and prognosis in Madrid, Spain. Clin Transl Oncol 2014;16:301-6.
20. McIlwain WR, Sood AJ, Nguyen SA, et al. Initial symptoms in patients with HPV-positive and HPV-negative oropharyngeal cancer. JAMA Otolaryngol Head Neck Surg 2014;140:441-7.
21. Gillison ML, Zhang Q, Jordan R, et al. Tobacco smoking and increased risk of death and progression for patients with p16-positive and p16-negative oropharyngeal cancer. J Clin Oncol 2012;30:2102-11.
22. Saito Y, Yoshida M, Ushiku T, et al. Prognostic value of p16 expression and alcohol consumption in Japanese patients with oropharyngeal squamous cell carcinoma. Cancer 2013;119:2005-11.